Carvedilol Tablet, Film Coated
Product Images NDC 50090-7850

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-7850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)
This data seems to be related to a medical study or clinical trial comparing different groups of individuals based on gender, age, health conditions like diabetes, heart conditions like ischemia, and possibly blood pressure levels. The text also mentions certain medications like spironolactone. It appears to include information on hazard ratios which are often used in epidemiological and medical research to assess the association between an exposure and an outcome.*
FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

FDA Label Image

Label Image (Lbl500907850)

Label Image (Lbl500907850)
This is a product label for a 35 MG tablet with the product number 9813-0. The label includes usage instructions and mentions that there are 90 tablets in the container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.